Clinical Social Workers in Oro Valley, AZ Accepting Medicare

4 Clinical Social Workers found. Showing 1 - 4

Mr. Daniel Randall Rock, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11311 N Seven Falls Dr, Oro Valley, AZ 85737 Phone: 520-283-3978    Fax: 520-797-1931

Ms. Barbara Mary Miller, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 272 W La Veta Ct, Oro Valley, AZ 85737 Phone: 520-229-1795

Shelley J Solomon, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 12470 N Rancho Vistoso Blvd, Suite 150, Oro Valley, AZ 85755 Phone: 520-400-0924    Fax: 520-742-2243

Mr. Patrick L Clark, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12286 N New Dawn Ave, Oro Valley, AZ 85755 Phone: 708-473-2043

News Archive

New study finds link between AAS use and mental health

There is a link between use of anabolic-androgenic steroids and reduced mental health later in life. This is the main conclusion of a new study on elite male strength athletes that researchers from the University of Gothenburg recently published in the British Journal of Sports Medicine.

Edifecs offers free CMS compliant solution for Medicare Administrative Contractors

Edifecs, Inc., the proven leader in healthcare transaction interoperability solutions, announced today it is providing a free Commercial-Off-The-Shelf (COTS) solution that is fully compliant with the new Centers for Medicare & Medicaid Services (CMS) requirements for Medicare Administrative Contractors (MACs).

AGO selects Sheridan Healthcare as strategic partner

Sheridan Healthcare, Inc. has expanded its presence in Central Florida with the affiliation of Anesthesiologists of Greater Orlando, Inc.

Report on the community-acquired pneumonia drug market

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the patent expiries of three blockbuster antibiotics - levofloxacin, moxifloxacin and piperacillin/tazobactam - will be the primary factors contributing to a decline of more than 15 percent in the community-acquired pneumonia drug market though 2018.

Dance Biopharm announces completion of $9.5 million convertible note and warrants financing

Dance Biopharm Inc., a privately-held biotechnology company focused on the development of inhaled insulin products to treat diabetes, today announced the completion of a $9.5 million convertible note and warrants financing.

Read more Medical News

› Verified 9 days ago